According to J.P. Morgan, Hologic HOLX, PT has been decreased from $24 to $20.
J.P. Morgan also announced a decrease in EPS estimates in FY11 from $1.25 to $1.24 and from $1.38 to $1.34 in FY12. FY13 EPS estimates are set at $1.42 and rating is set to Overweight.
HOLX closed yesterday at $18.05
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
|---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
